NASDAQ:ARDX

Ardelyx News Headlines

$7.02
-0.01 (-0.14 %)
(As of 04/13/2021 12:32 PM ET)
Add
Compare
Today's Range
$6.98
Now: $7.02
$7.20
50-Day Range
$6.10
MA: $6.80
$7.86
52-Week Range
$4.96
Now: $7.02
$8.35
Volume25,735 shs
Average Volume1.05 million shs
Market Capitalization$692.73 million
P/E RatioN/A
Dividend YieldN/A
Beta2.02

Headlines

Ardelyx (NASDAQ ARDX) News Headlines Today

SourceHeadline
Ardelyx Announces Upcoming Data Presentation at ISN World Congress of Nephrology 2021Ardelyx Announces Upcoming Data Presentation at ISN World Congress of Nephrology 2021
finance.yahoo.com - April 12 at 9:31 AM
Ardelyx (NASDAQ:ARDX) Sees Strong Trading VolumeArdelyx (NASDAQ:ARDX) Sees Strong Trading Volume
americanbankingnews.com - April 9 at 11:02 AM
Insider Selling: Ardelyx, Inc. (NASDAQ:ARDX) Insider Sells 5,000 Shares of StockInsider Selling: Ardelyx, Inc. (NASDAQ:ARDX) Insider Sells 5,000 Shares of Stock
americanbankingnews.com - April 8 at 7:34 PM
$1.10 Million in Sales Expected for Ardelyx, Inc. (NASDAQ:ARDX) This Quarter$1.10 Million in Sales Expected for Ardelyx, Inc. (NASDAQ:ARDX) This Quarter
americanbankingnews.com - April 8 at 4:34 AM
Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly? - NasdaqIs Ardelyx (NASDAQ:ARDX) Using Debt Sensibly? - Nasdaq
nasdaq.com - April 7 at 3:41 PM
Global End-Stage Renal Disease Pipeline Insight Report 2021 Featuring Aronora, Ionis Pharmaceuticals, Janssen Research & Development, & Ardelyx - ResearchAndMarkets.com - Business WireGlobal End-Stage Renal Disease Pipeline Insight Report 2021 Featuring Aronora, Ionis Pharmaceuticals, Janssen Research & Development, & Ardelyx - ResearchAndMarkets.com - Business Wire
businesswire.com - April 7 at 10:41 AM
Ardelyx (NASDAQ:ARDX) Shareholders Booked A 47% Gain In The Last Three Years - Yahoo FinanceArdelyx (NASDAQ:ARDX) Shareholders Booked A 47% Gain In The Last Three Years - Yahoo Finance
finance.yahoo.com - April 7 at 10:41 AM
Ardelyx (NASDAQ:ARDX) Shareholders Booked A 47% Gain In The Last Three YearsArdelyx (NASDAQ:ARDX) Shareholders Booked A 47% Gain In The Last Three Years
finance.yahoo.com - April 7 at 10:41 AM
Ardelyx (NASDAQ:ARDX) Sets New 52-Week High at $8.36Ardelyx (NASDAQ:ARDX) Sets New 52-Week High at $8.36
americanbankingnews.com - April 6 at 10:38 AM
-$0.32 Earnings Per Share Expected for Ardelyx, Inc. (NASDAQ:ARDX) This Quarter-$0.32 Earnings Per Share Expected for Ardelyx, Inc. (NASDAQ:ARDX) This Quarter
americanbankingnews.com - April 6 at 6:14 AM
Ardelyx (NASDAQ:ARDX) Shares Up 6%Ardelyx (NASDAQ:ARDX) Shares Up 6%
americanbankingnews.com - April 5 at 12:06 PM
Ardelyx (ARDX) Stock Jumps 6.8%: Will It Continue to Soar? - Yahoo FinanceArdelyx (ARDX) Stock Jumps 6.8%: Will It Continue to Soar? - Yahoo Finance
finance.yahoo.com - April 1 at 2:38 PM
Ardelyx (ARDX) Stock Jumps 6.8%: Will It Continue to Soar?Ardelyx (ARDX) Stock Jumps 6.8%: Will It Continue to Soar?
finance.yahoo.com - April 1 at 9:37 AM
Ardelyx Stock Appears To Be Modestly OvervaluedArdelyx Stock Appears To Be Modestly Overvalued
finance.yahoo.com - April 1 at 4:36 AM
Ardelyx Announces Poster Presentations, Educational Symposium, and Exhibitor Showcase at National Kidney Foundation 2021 Virtual Spring Clinical MeetingsArdelyx Announces Poster Presentations, Educational Symposium, and Exhibitor Showcase at National Kidney Foundation 2021 Virtual Spring Clinical Meetings
finance.yahoo.com - March 30 at 5:33 PM
Wedbush Initiates Coverage on Ardelyx (NASDAQ:ARDX)Wedbush Initiates Coverage on Ardelyx (NASDAQ:ARDX)
americanbankingnews.com - March 29 at 10:02 AM
2 “Strong Buy” Biotech Stocks With Major Catalysts Approaching2 “Strong Buy” Biotech Stocks With Major Catalysts Approaching
finance.yahoo.com - March 26 at 3:26 PM
Ardelyx, Inc. Forecasted to Post Q2 2021 Earnings of ($0.31) Per Share (NASDAQ:ARDX)Ardelyx, Inc. Forecasted to Post Q2 2021 Earnings of ($0.31) Per Share (NASDAQ:ARDX)
americanbankingnews.com - March 25 at 8:04 AM
Ardelyx (NASDAQ:ARDX) Stock Price Down 8.2%Ardelyx (NASDAQ:ARDX) Stock Price Down 8.2%
americanbankingnews.com - March 24 at 2:50 PM
Ardelyx (NASDAQ:ARDX) Trading Down 8.2%Ardelyx (NASDAQ:ARDX) Trading Down 8.2%
americanbankingnews.com - March 24 at 2:50 PM
Ardelyx, Inc. (NASDAQ:ARDX) Forecasted to Earn Q1 2021 Earnings of ($0.32) Per ShareArdelyx, Inc. (NASDAQ:ARDX) Forecasted to Earn Q1 2021 Earnings of ($0.32) Per Share
americanbankingnews.com - March 24 at 8:44 AM
Ardelyx (NASDAQ:ARDX) Coverage Initiated at WedbushArdelyx (NASDAQ:ARDX) Coverage Initiated at Wedbush
americanbankingnews.com - March 22 at 4:58 PM
 Analysts Expect Ardelyx, Inc. (NASDAQ:ARDX) Will Post Quarterly Sales of $1.10 Million Analysts Expect Ardelyx, Inc. (NASDAQ:ARDX) Will Post Quarterly Sales of $1.10 Million
americanbankingnews.com - March 21 at 1:12 AM
Hyperkalemia - Japan Market Insights, Epidemiology and Forecast to 2030 - ResearchAndMarkets.com - Business WireHyperkalemia - Japan Market Insights, Epidemiology and Forecast to 2030 - ResearchAndMarkets.com - Business Wire
businesswire.com - March 18 at 9:19 AM
Ardelyx (ARDX) Announces Muna Bhanji, R.Ph, to Board - StreetInsider.comArdelyx (ARDX) Announces Muna Bhanji, R.Ph, to Board - StreetInsider.com
streetinsider.com - March 15 at 5:43 PM
Ardelyx Appoints Muna Bhanji, R.Ph, to its Board of DirectorsArdelyx Appoints Muna Bhanji, R.Ph, to its Board of Directors
finance.yahoo.com - March 15 at 12:43 PM
Growing Ardelyx, on eve of FDA decision on chronic kidney disease drug, sets up East Coast headquarters - San Francisco Business Times - San Francisco Business TimesGrowing Ardelyx, on eve of FDA decision on chronic kidney disease drug, sets up East Coast headquarters - San Francisco Business Times - San Francisco Business Times
bizjournals.com - March 8 at 6:45 PM
Form 8-K ARDELYX, INC. For: Mar 08 - StreetInsider.comForm 8-K ARDELYX, INC. For: Mar 08 - StreetInsider.com
streetinsider.com - March 8 at 1:41 PM
Ardelyx EPS misses by $0.06, beats on revenue - Seeking AlphaArdelyx EPS misses by $0.06, beats on revenue - Seeking Alpha
seekingalpha.com - March 8 at 1:41 PM
Ardelyx (ARDX) Reports Q4 Loss, Misses Revenue Estimates - Yahoo FinanceArdelyx (ARDX) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
finance.yahoo.com - March 8 at 1:41 PM
Ardelyx (ARDX) Reports Q4 Loss, Misses Revenue EstimatesArdelyx (ARDX) Reports Q4 Loss, Misses Revenue Estimates
finance.yahoo.com - March 8 at 1:41 PM
Ardelyx Reports Fourth Quarter and Full Year 2020 Financial Results and Recent HighlightsArdelyx Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights
finance.yahoo.com - March 8 at 8:41 AM
Ardelyx, Inc. (NASDAQ:ARDX): When Will It Breakeven? - Yahoo FinanceArdelyx, Inc. (NASDAQ:ARDX): When Will It Breakeven? - Yahoo Finance
finance.yahoo.com - March 2 at 10:04 AM
Ardelyx, Inc. (NASDAQ:ARDX): When Will It Breakeven?Ardelyx, Inc. (NASDAQ:ARDX): When Will It Breakeven?
finance.yahoo.com - March 2 at 10:04 AM
Ardelyx Before The April PDUFA - Seeking AlphaArdelyx Before The April PDUFA - Seeking Alpha
seekingalpha.com - February 27 at 6:35 PM
American Kidney Fund Announces 2021 Class of Corporate Members Aligned in Fighting Kidney Disease - Yahoo FinanceAmerican Kidney Fund Announces 2021 Class of Corporate Members Aligned in Fighting Kidney Disease - Yahoo Finance
finance.yahoo.com - February 25 at 9:50 AM
Ardelyx to Present at the 10th Annual SVB Leerink Global Healthcare Conference - Yahoo FinanceArdelyx to Present at the 10th Annual SVB Leerink Global Healthcare Conference - Yahoo Finance
finance.yahoo.com - February 17 at 8:21 AM
Ardelyx to Present at the 10th Annual SVB Leerink Global Healthcare ConferenceArdelyx to Present at the 10th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 17 at 8:21 AM
10 Best Small-Cap Biotech Stocks Under $10 in 202110 Best Small-Cap Biotech Stocks Under $10 in 2021
finance.yahoo.com - February 8 at 10:55 AM
Onetime CEO of Genentech dies from Covid complications - San Francisco Business TimesOnetime CEO of Genentech dies from Covid complications - San Francisco Business Times
bizjournals.com - January 28 at 12:48 AM
Is Ardelyx, Inc. (NASDAQ:ARDX) Popular Amongst Institutions? - Yahoo FinanceIs Ardelyx, Inc. (NASDAQ:ARDX) Popular Amongst Institutions? - Yahoo Finance
finance.yahoo.com - January 16 at 3:50 PM
Is Ardelyx, Inc. (NASDAQ:ARDX) Popular Amongst Institutions?Is Ardelyx, Inc. (NASDAQ:ARDX) Popular Amongst Institutions?
finance.yahoo.com - January 16 at 3:50 PM
Cantor initiates with Overweight rating for Scynexis and Ardelyx on potential drug approval - Seeking AlphaCantor initiates with Overweight rating for Scynexis and Ardelyx on potential drug approval - Seeking Alpha
seekingalpha.com - January 6 at 12:39 PM
Cantor Fitzgerald Starts Ardelyx, Inc (ARDX) at Overweight - StreetInsider.comCantor Fitzgerald Starts Ardelyx, Inc (ARDX) at Overweight - StreetInsider.com
streetinsider.com - January 5 at 6:54 PM
Is ARDX A Good Stock To Buy Now According To Hedge Funds? - Yahoo FinanceIs ARDX A Good Stock To Buy Now According To Hedge Funds? - Yahoo Finance
finance.yahoo.com - December 19 at 12:53 AM
Is ARDX A Good Stock To Buy Now According To Hedge Funds?Is ARDX A Good Stock To Buy Now According To Hedge Funds?
finance.yahoo.com - December 19 at 12:53 AM
Reassessing Ardelyx - Seeking AlphaReassessing Ardelyx - Seeking Alpha
seekingalpha.com - December 14 at 7:47 PM
Friday 12/11 Insider Buying Report: ARDX, BCATFriday 12/11 Insider Buying Report: ARDX, BCAT
nasdaq.com - December 13 at 9:36 AM
Ardelyx - BenzingaArdelyx - Benzinga
benzinga.com - December 12 at 6:31 PM
U.S. Consumer Sentiment Unexpectedly Improves In December - NasdaqU.S. Consumer Sentiment Unexpectedly Improves In December - Nasdaq
nasdaq.com - December 11 at 12:06 PM
This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.